QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 发表日期：2018    内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078 study 会议论文 作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05 CheckMate 078: Patient-Reported Outcomes (PROs) With Nivolumab vs Docetaxel in Advanced Non-Small Cell Lung Cancer (NSCLC) 会议论文 作者:  Wu, Y.;  Chang, J.;  Zhang, L.;  Tu, H.;  Wu, L. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Advanced NSCLC  Nivolumab  Docetaxel  Patient-Reported Outcomes   Trastuzumab plus docetaxel and capecitabine for first-line treatment of Her2-positive advanced gastric cancer: A phase II, multi-center, open-label, singlearm study. 会议论文 作者:  Wang, Feng;  Liu, Tian Shu;  Yuan, Xianglin;  Gu, Kangsheng;  Yuan, Ying 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05 Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078 study 会议论文 CANCER RESEARCH, 2018-07-01 作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03